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Abstract
Background: Vitamin D receptors have been mapped throughout the brain suggesting a role for vitamin D in
psychosomatic disorders. Results from previous epidemiological studies on relation between vitamin D status and
depression are equivocal. Also, limited information is available relating vitamin D status with depression in young
adult US population.
Methods: Data from the third National Health and Nutrition Examination Survey were used to assess association
between serum vitamin D and depression in 7970 non-institutionalized US residents, aged 15-39 y. Assessment of
depression was done using the Diagnostic Interview Schedule developed by the National Institute of Mental
Health. After accounting for several confounding variables in multivariate logistic regression analysis, we estimated
odds ratios (OR) for having depression in vitamin D deficient persons in comparison to vitamin D sufficient
persons.
Results: Women, non-Hispanic blacks, persons living below poverty, persons who did not consume supplements,
persons living in South and West regions and in urban areas, persons with higher BMI, and persons with current
depression had higher prevalence of vitamin D deficiency compared to their counterparts. OR for having current
depressive episodes in persons with serum vitamin D ≤ 50 nmol/L is significantly higher relative to those with
serum vitamin D ≥ 75 nmol/L (OR = 1.85; P = 0.021).
Conclusions: In this large population based study, likelihood of having depression in persons with vitamin D
deficiency is significantly higher compared to those with vitamin D sufficiency. Early diagnosis and intervention are
paramount because coexistence of vitamin D deficiency and depression has serious negative consequences on
health.
Introduction
Low vitamin D status is a widespread problem in the US
[1,2]. Research has shown that serum vitamin D concen-
trations previously considered in the normal range are
not sufficient for optimal health [3]. Vitamin D plays a
role in a wide range of ailments such as osteoporosis,
cancer, cardiovascular diseases, and diabetes [4,5].
Recently, a role for vitamin D in cognitive function and
mental health has been reported [6,7]. Vitamin D con-
centrations have been shown to be low in patients suf-
fering from mood disorders and have been associated
with cognitive function [8,9].
Depression is one of the leading causes of disability in
the US among young adults. In the US, in a given year,
about 26% of population, aged ≥18 years suffer from a
diagnosable mental disorder and about 6% (1 in 17) suffer
from a serious mental disorder [10]. Several mechanisms
of action have been proposed to explain the association
between vitamin D and depression. The role of calcitriol
or 1, 25 dihydroxy cholecalciferol, the bioactive form of
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vitamin D, in brain tissue has been confirmed by the pre-
sence of vitamin D receptors (VDR) and hydroxylases in
various brain regions [11,12]. One area where VDR and
hydroxylases have been found is the amygdala, which is
the center of the limbic system, where behavior and emo-
tions are regulated [13]. Vitamin D has been reported to
exert a neuroprotective function through several
mechanisms. Calcitriol regulates calcium concentrations
intra- and extracellularly in neurons, consequently redu-
cing toxicity caused by excess calcium [14-16].
A few studies have found an association between
serum vitamin D concentrations and depression [17-20].
Light therapy has been shown to improve the depression
in adjunction with antidepressants, which may be in part
due to improved vitamin D synthesis associated with
light therapy [21]. Majority of the studies relating vita-
min D status with depression are based either on a
small sample size or non-representative of the US popu-
lation. Very little is reported on the association between
vitamin D concentrations and depression in young adult
US population. Overall, the previous studies on the
association between vitamin D status and depression
yielded equivocal results [22-25]. Therefore, the aim of
this study was to investigate the association between
serum vitamin D concentrations (25 hydroxy cholecalci-
ferol or calcidiol) and depression in a large, nationally
representative sample survey of the US population, the




NHANES III was conducted by the National Center for
Health Statistics (NCHS) of the Centers for Disease
Control and Prevention (CDC) in 89 different geo-
graphic locations across the US, between the years of
1988 and 1994. Health and nutritional status of partici-
pants were collected using physical examinations, bio-
chemical measurements of blood and urine samples,
and health questionnaires. The physician administered
physical examinations were performed in the mobile
examination centers (MEC). All participants signed
informed consent before participating in NHANES.
A complete description of the survey procedures are
described elsewhere [26].
Blood was collected by venipuncture at MECs, accord-
ing to standard protocol. Centrifugation was used to
separate serum after blood samples were held at room
temperature for 30-60 minutes. Samples were sent to
the CDC from MECs in a frozen state (-20°C) for bio-
chemical analysis. Serum vitamin D concentrations were
analyzed at the National Center for Environmental
Health, CDC, Atlanta, GA using the DiaSorin RIA kit
(Stillwater, MN) in participants >12 y of age [27].
Study Sample
The current study sample initially consisted of 18875
participants whose serum vitamin D concentrations
were measured. The diagnostic assessment for depres-
sion using the Diagnostic Interview Schedule (DIS) was
collected from 8773 persons, aged 15-39 y. Participants
with missing values for vitamin D concentrations,
depression variables, and confounding variables were
excluded from the analysis. Also, pregnant and lactating
women were excluded from the study (n = 280). After
applying the aforementioned exclusion criteria, the final
study sample consisted of 7970 participants, represent-
ing over 90 million US non-institutionalized, civilian
population (weighted n = 90759698). The mean (±SE)
age of the study population was 27.5 (±0.16) y.
Description of depression variables
The mental health component of the survey was collected
in the MECs by trained interviewers using automated data
entry, as part of the MEC Youth Questionnaire for exami-
nees 15-16 y of age and as part of the MEC Adult Ques-
tionnaire for examinees 17-39 y of age. Depression was
assessed using the DIS developed by the National Institute
of Mental Health. The DIS is a complicated questionnaire
with a number of parallel series of questions. The detailed
description of the DIS questionnaire is described in Plan
and Operation of the NHANES III [26,28]. The depression
assessment derived from the DIS was used to make diag-
noses based on the third edition of the Diagnostic and
Statistical Manual of Mental Disorders (DSM III).
Below is the description of the DIS variables used in
the data analysis.
1. SAS code, MQPDEP: DSMIII major depression
2. SAS code, MQPDYSA: >2 yrs of predominately
depressive mood. Criteria for depression on the
DSM-III are encompassed in this variable.
3. SAS code, MQPG35: Depressed spell now- “Are
you in one of these spells of feeling low or disinter-
ested and having some of these other problems
now?”
Description of confounding variables
Sex, age, race-ethnicity, geographical region, rural/urban
setting, poverty income ratio, use of vitamin/mineral sup-
plements and prescription medications, body mass index
(BMI), and serum creatinine concentrations were used as
potential confounding variables. These variables are
spread over 4 databases (Household Adult File, House-
hold Youth File, Examination File, and Laboratory File)
[29-32]. Data were collected on geographical location
(Northeast, Midwest, West, and South and urban/rural)
of sampled persons. Persons race-ethnicity was classified
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into non-Hispanic white, non-Hispanic black, Mexican
Americans/Hispanic, and Other categories. Individuals
who reported taking vitamin/mineral supplements and
prescription medications 30 day prior to the survey admi-
nistered were classified as consumers of supplements and
medications, respectively. Poverty income ratio was used
to classify the person’s socioeconomic status. Poverty
income ratio is the ratio of a family’s income to their
appropriate threshold income. Persons with poverty
income ratio <1.0, 1.0 to <2.0, 2.0 to <3.0, and ≥3.0 were
considered as those below poverty line, low-middle
income, high-middle income, and high income, respec-
tively. BMI values <18.5, 18.5 to <25, 25 to <30, and
≥30 kg/m2 were considered underweight, healthy weight,
overweight, and obese, respectively.
Data analysis
Statistical analysis was carried out with SUDAAN statisti-
cal software (SAS-callable version 10.0 Research Triangle
Institute, Research Triangle Park, NC) and SAS (Statistical
Analysis Software for Windows, version 9.1, Cary, NC). As
per NHANES analytic guidelines, SUDAAN statistical
software was used to account for NHANES’s complex
survey design. Variance estimates were computed using
the Taylor Linearization Method assuming a design with
replacement. Data were sorted by strata (SDPSTRA6) and
Primary Sample Unit (SDPPSU6). Data were adjusted with
the final MEC sample weight (WTPFEX6) in accordance
to the NHANES III analytic and reporting guidelines [33].
Sample weights were used to correct for unequal probabil-
ity of selection due to the oversampling of certain
subgroups and to correct for non-response bias and differ-
ences between the sample and the total US population.
Although the vitamin D concentrations were not nor-
mally distributed, logarithmic transformation was not
performed because in the analysis, serum vitamin D
concentration was used as a categorical variable rather
than a continuous variable. Serum vitamin D concentra-
tions were divided into three categories, i.e., deficient
(<50 nmol/L), insufficient (50-75 nmol/L), and sufficient
(>75 nmol/L). The Chi-square test was used to find dif-
ferences in the proportion of persons with vitamin D
deficiency in various categories of the US population
and in the participants with depression. Unadjusted and
multivariate adjusted logistic regressions were used to
generate the odds ratio (OR) and their 95% confidence
intervals (CIs) for vitamin D concentrations and depres-
sion. In all analyses, the statistical significance was set at
a = 0.05.
Results
The study sample consisted of ≈54% women and ≈67%
non-Hispanic black and Mexican American/Hispanics.
Of 7970 participants, ≈30.6% lived in the Northeast and
Midwest regions, ≈48% lived in rural areas, ≈27% lived
below poverty, ≈23% used prescription medicine, ≈28%
used vitamin/mineral supplements, ≈47% had BMI
≥ 25 kg/m2, and ≈4% reported that they had current
depression at the time of the survey (Table 1).
Sample sizes and serum vitamin D concentrations for
depression variables and confounding variables are
reported in Table 2 and Table 3, respectively. The preva-
lences of vitamin D deficiency for depression and con-
founding variables are reported in Table 4 and Table 5,
respectively. Higher prevalences of vitamin D deficiency
were observed in women compared to men, in non-
Hispanic black compared to non-Hispanic white and
Mexican Americans/Hispanics, in persons below poverty
compared to those above poverty, in persons who did not
consume vitamin/mineral supplements compared to
those who consumed supplements, in persons living in
the South and in the West regions compared to those
living in the Northeast and in the Midwest, in persons
living in the urban setting compared to those living in
the rural setting, in persons with higher BMI (≥25 kg/m2)
compared to those with lower BMI (<25 kg/m2), in per-
sons who had depression >2 y compared to those who
did not have depression >2 y, and in persons with depres-
sion at the time of the survey compared to those who did
not report having depression at the time of the survey.
Table 1 Characteristics of study population: the Third





Live in South and West regions 70.4
Live in urban areas 51.9
Supplement use 2 28.4
Prescription medicine use 3 23.1
Persons living below poverty 4 27.2
Persons with overweight and obesity 5 47.2
Persons had a major depression 7.9
Persons had depression episodes longer >2 y 11.9
Persons having depression currently 6 4.0
Age (y) 27.5 ± 0.2
Poverty income ratio 7 2.74 ± 0.1
Body mass index (kg/m2) 25.3 ± 0.1
1 n = 7970. Values are % or means ± standard error of mean.
2 Vitamin/mineral supplement use 1 month prior to the survey.
3 Prescription medicine use 1 month prior to the survey.
4 Poverty was defined as having poverty income ratio <1.0. Poverty income
ratio is the ratio of a family’s income to their appropriate threshold income.
5 Overweight and obesity were defined as having BMI 25 to <30 kg/m2 and
≥30 kg/m2, respectively.
6 Based on the question “Are you in one of these spells of feeling low or
disinterested and having some of these other problems now”?.
7 The ratio of a family’s income to their appropriate threshold income.
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The OR and 95% confidence intervals for having
depression and vitamin D deficiency are presented in
Table 6. In unadjusted regression analysis, serum vita-
min D concentrations were associated with depressive
mood >2 y (OR: 1.43; P = 0.022) and current depression
status (OR: 2.01; P < 0.001). When the analysis was
adjusted for confounding variables (sex, age, gender,
race-ethnicity, poverty income ratio, vitamin/mineral
supplement and medication use, geographical location,
rural/urban living, BMI, and serum creatinine) in the
multivariate regression model, only the association
between serum vitamin D and current depression status
was significant (OR: 1.85; P = 0.021).
Discussion
In this study, we investigated the association between
vitamin D status and depression in the US population.
Overall, the prevalence of suboptimal serum vitamin D
concentration (≤75 nmol/L) was ≈50%. Out of 7970,
≈20% were vitamin D deficient (serum vitamin D <50
nmol/L) and ≈30% were moderately vitamin D deficient
(serum vitamin D 50-75 nmol/L). Higher prevalence of
vitamin D deficiency was found in women, in non-Hispa-
nic blacks, in people with higher BMI, in people with
lower income, in people living in urban areas, and in peo-
ple living in the South compared to their counterparts.
These results are in agreement with the findings
reported earlier [34,35]. What is surprising is that the
prevalence of vitamin D deficiency was higher in per-
sons living in the South compared to those living in the
Northeast and Midwest given the more sun exposure in
the South than in the North and that the direct sun
exposure (UV light) leads to synthesis of endogenous
vitamin D. This is likely due to the timing of the blood
collection in the NHANES III. In order to avoid extreme
cold climate in the Northeast and Midwest and warm
climate in the South to prevent the damage to the MEC
and to improve the participation, the NHANES III was
conducted during summer in the Northeast and Mid-
west and during winter in the South (26). This could
have significantly affected the prevalence of vitamin D
deficiency in both these regions and more likely under-
estimated the prevalence of vitamin D deficiency in the
Table 2 Serum vitamin D concentrations for depression
variables of study population: the Third National Health
and Nutrition Examination Survey¹
Characteristic Serum vitamin D 2
(nmol/L)
Person had a major depression (n = 7877)
Yes (n = 622) 79.8 ± 2.3
No (n = 7255) 77.9 ± 1.2
Persons had depression episodes longer >2 y (n = 7970)
Yes (n = 948) 75.0 ± 1.8
No (n = 7022) 78.4 ± 1.2
Persons having depression currently
(n = 1221)
Yes (n = 322) 74.9 ± 2.7
No (n = 889) 81.2 ± 2.3
1Depression was assessed using the Diagnostic Interview Schedule (DIS)
developed by the National Institute of Mental Health.
2 Values are means ± standard error of mean.
Table 3 Serum vitamin D concentrations for all
confounding variables of study population: the Third
National Health and Nutrition Examination Survey
Characteristic Serum vitamin D1
(nmol/L)
Sex
Men (n = 3652) 80.5 ± 1.3
Women (n = 4318) 75.7 ± 1.4
Race-ethnicity
Non-Hispanic white (n = 2281) 86.5 ± 1.4
Non-Hispanic black (n = 2634) 48.5 ± 1.2
Mexican American/Hispanic (n = 2711) 65.3 ± 1.2
Other (n = 344) 63.0 ± 1.5
Geographical location
Northeast (n = 958) 85.0 ± 2.3
Midwest (n = 1482) 86.3 ± 3.3
South (n = 3460) 71.8 ± 1.7
West (n = 2070) 72.6 ± 1.8
Urbanization
Urban living (n = 4135) 72.5 ± 1.3
Rural living (n = 3795) 83.6 ± 2.0
Supplement use 2
Yes (n = 2262) 81.0 ± 1.4
No (n = 4992) 75.9 ± 1.4
Prescription medicine use 3
Yes (n = 1845) 79.3 ± 1.7
No (n = 5409) 77.2 ± 1.2
Poverty income ratio 4
<1.0 (below poverty) (n = 2170) 69.9 ± 1.4
2.0-<3.0 (low-middle income) (n = 2058) 76.4 ± 1.7
3.0-<4.0 (high-middle income) (n = 2267) 79.3 ± 1.4
≥4.0 (high income) (n = 818) 84.5 ± 2.1
Body mass index (Kg/m2)
Underweight (<18.5) (n = 277) 84.7 ± 3.5
Normal weight (18.5-<25) (n = 3911) 82.4 ± 1.3
Overweight (25-<30) (n = 2179) 76.3 ± 1.5
Obese (≥30) (n = 1583) 65.6 ± 1.5
Serum creatinine
<70 μmol/L (n = 446) 70.2 ± 3.0
70-124 μmol/L (n = 7068) 78.6 ± 1.2
>124 μmol/L (n = 302) 72.2 ± 2.7
1 Values are means ± standard error of mean.
2 Vitamin/mineral supplement use 1 month prior to the survey.
3 Prescription medicine use 1 month prior to the survey.
4 The ratio of a family’s income to their appropriate threshold income.
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North and overestimated the prevalence of vitamin D
deficiency in the South.
A direct relation was observed between vitamin D
deficiency and the depression variable “currently having
depression episodes” in the multivariate adjusted regres-
sion model. This variable is the most relevant one,
because this survey question was asked to specify the
current depression status of the participants which coin-
cides with the blood collection for vitamin D assay. In
this study, participants with a current episode of depres-
sion had 8.4% lower concentrations of serum vitamin D
compared to those who did not report having depres-
sion. This result is in accordance to previous epidemio-
logic studies [18-20]. In the Longitudinal Aging Study
Amsterdam, Hoogendijk et al [20] found that serum
vitamin D concentrations were 14% lower in persons
with major and minor depressions and that the vitamin
D status was associated with both major and minor
depressions. Additionally, a randomized, double blind
study in obese persons conducted by Jorde et al [19]
reported that after 1 year of supplementation with vita-
min D, subjects had significantly lower Beck Depression
Inventory score and lower circulating parathyroid hor-
mone without concomitant increase in calcium com-
pared to those who received placebo. This study
suggests a possible causal relationship between vitamin
D status and depression.
In contrast to our findings, recently, Zhao et al [23]
utilizing the data reported in NHANES 2005-2006 (n =
3916), found no significant association between serum
concentrations of vitamin D and the presence of major
depression, minor depression, and moderate to severe
depression. However, they observed a trend of decreas-
ing depression with increasing quartiles of serum vita-
min D concentration in both unadjusted and multivari-
ate adjusted regression models. Pan et al [22] also
reported no significant association between vitamin D
status and depression in Chinese adults aged, 50-70 y
(n = 3262). It is very difficult to assess whether the dif-
ferences observed between studies are due to true phy-
siological differences or due to differences in
methodology such as characteristics of study population,
nutritional status of study participants, timing of the
blood collection, assay used for the analysis of serum
vitamin D, survey assessment used to collect the infor-
mation on depression, and statistical adjustment used in
regression models.
The mechanism through which vitamin D plays a role
in metal health is not clearly understood. Active vitamin
D enhances glutathione metabolism in neurons, there-
fore, promotes antioxidant activities that protect them
from oxidative degenerative processes [16,17]. Vitamin D
also stimulates the expression of nerve growth factor and
promotes neuritogenesis [15,36]. Several studies have
shown that vitamin D is involved in brain development
and that its deficiency results in altered morphology
(enlarged ventricles and reduced cortical thickness as it
occurs in schizophrenia) and behavior in adulthood
[37,38]. Moreover, it has been shown that vitamin D reg-
ulates gene expression of tyrosine hydroxylase, an essen-
tial enzyme involved in the synthesis of norepinephrine
and dopamine [39]. Both neurotransmitters are involved
in mood regulation and depression. Because vitamin D
regulates calcium homeostasis, membrane permeability
and axonal conduction, it is thought to have an indirect
role in the regulation of neurotransmission.
Table 4 Prevalence of vitamin D deficiency according to the depression status of study population: the Third National













Person had a major depression (n = 7877) 0.86
Yes 622 19.3 (215) 29.0 (191) 51.7 (216)
No 7255 19.6 (2453) 30.6 (2458) 49.8 (2344)
Person had depression longer >2 y (n = 7970) 0.039
Yes 948 24.7 (379) 29.6 (310) 45.7 (259)
No 7022 19.1 (2322) 30.5 (2369) 50.4 (2331)
Person having depression currently (n = 1221) 0.003
Yes 322 27.4 (138) 22.9 (99) 49.7 (95)
No 889 14.5 (276) 32.6 (285) 52.9 (328)
1 Depression was assessed using the Diagnostic Interview Schedule developed by the National Institute of Mental Health.
2 Serum concentrations of 25 (OH) vitamin D <50 nmol/L.
3 Serum concentrations of 25 (OH) vitamin D 50-75 nmol/L.
4 Serum concentrations of 25 (OH) vitamin D >75 nmol/L.
5 Significance of depression variable for proportions of persons with vitamin D deficiency, insufficiency, and sufficiency in the c2 test.
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Conclusion
The likelihood of having depression in vitamin D deficient
persons is significantly higher compared to those with ade-
quate vitamin D status. A strength of this study is that the
data were obtained from a nationally representative sam-
ple survey conducted on civilian residents, hence the
results of this study can be applied to the population at
large. Other strengths include the large sample size (n =
7970) and the use of several variables that influence serum
vitamin D in the data analysis which allowed us to adjust
the regression models for various confounding variables.
Due to the cross-sectional nature of this study, the results
should not be viewed in terms of cause and effect
relationship.
It is not known, whether vitamin D deficiency leads to
the depression or depression leads to the vitamin D defi-
ciency. Further studies are needed in deciphering the pre-
cise role of vitamin D in psychosomatic disorders.
Although the direction of the cause and effect relation
between depression and vitamin D deficiency is not
known clearly at this time, in public health perspective,
the coexistence of vitamin D and depression in the US
population at large is a concern. It is important to identify
persons who are at risk for vitamin D deficiency and/or
Table 5 Prevalence of vitamin D deficiency in various categories of study population: the third National Health and






All subjects 19.6 (2701) 30.4 (2679) <0.001
Sex <0.001
Men 15.5 (964) 31.1 (1304)
Women 23.6 (1737) 29.8 (1375)
Race-ethnicity <0.001
Non-Hispanic white 10.1 (215) 28.5 (648)
Non-Hispanic black 60.0 (1588) 28.7 (745)
Mexican American/Hispanic 26.5 (790) 43.1 (1151)
Other 32.4 (108) 38.0 (135)
Geographical location <0.001
Northeast 12.4 (288) 27.5 (284)
Midwest 11.3 (391) 28.9 (493)
South 27.1 (1467) 30.4 (1053)
West 23.5 (555) 35.0 (849)
Urbanization <0.001
Urban living 25.1 (1612) 31.6 (1392)
Rural living 14.2 (1089) 29.2 (1287)
Supplement use 5 <0.001
Yes 15.8 (627) 29.5 (753)
No 22.8 (1890) 30.1 (1657)
Poverty income ratio 6 <0.001
<1.0 (below poverty line) 28.8 (849) 34.3 (797)
2.0-<3.0 (low-middle income) 21.2 (745) 29.0 (672)
3.0-<4.0 (high-middle income) 17.1 (692) 30.7 (725)
≥4.0 (high income) 13.9 (192) 27.8 (242)
Body mass index (kg/m2) <0.001
Underweight (<18.5) 15.4 (71) 27.6 (98)
Normal weight (18.5-<25) 16.0 (1128) 28.0 (1271)
Overweight (25-<30) 20.3 (749) 31.9 (774)
Obese (≥30) 31.0 (748) 36.3 (525)
1 Data associated with prescription medicine use and serum creatinine concentrations are not presented because these two variables were found non-significant
in the c2 test for proportions of vitamin D deficiency, insufficiency, and sufficiency. Data associated with vitamin D sufficiency (>75 nmol/L) are not shown.
2 Serum concentrations of 25 (OH) vitamin D <50 nmol/L.
3 Serum concentrations of 25 (OH) vitamin D 50-75 nmol/L.
4 Significance of variable for proportions of persons with vitamin D deficiency, insufficiency, and sufficiency in the c2 test.
5 Vitamin/mineral supplement use 1 month prior to the survey.
6 The ratio of a family’s income to their appropriate threshold income.
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for depression and to intervene early because these two
conditions have enormous negative consequences on long
term health.
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